Literature DB >> 31124430

Innate and Adaptive Immune Responses during Listeria monocytogenes Infection.

Sarah E F D'Orazio1.   

Abstract

It could be argued that we understand the immune response to infection with Listeria monocytogenes better than the immunity elicited by any other bacteria. L. monocytogenes are Gram-positive bacteria that are genetically tractable and easy to cultivate in vitro, and the mouse model of intravenous (i.v.) inoculation is highly reproducible. For these reasons, immunologists frequently use the mouse model of systemic listeriosis to dissect the mechanisms used by mammalian hosts to recognize and respond to infection. This article provides an overview of what we have learned over the past few decades and is divided into three sections: "Innate Immunity" describes how the host initially detects the presence of L. monocytogenes and characterizes the soluble and cellular responses that occur during the first few days postinfection; "Adaptive Immunity" discusses the exquisitely specific T cell response that mediates complete clearance of infection and immunological memory; "Use of Attenuated Listeria as a Vaccine Vector" highlights the ways that investigators have exploited our extensive knowledge of anti-Listeria immunity to develop cancer therapeutics.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31124430     DOI: 10.1128/microbiolspec.GPP3-0065-2019

Source DB:  PubMed          Journal:  Microbiol Spectr        ISSN: 2165-0497


  16 in total

1.  Enrichment of Neutrophils and Monocytes From the Liver Following Either Oral or Intravenous Listeria monocytogenes Infection.

Authors:  Michelle G Pitts; Sarah E F D'Orazio
Journal:  Curr Protoc Immunol       Date:  2020-09

2.  Role of GlnR in Controlling Expression of Nitrogen Metabolism Genes in Listeria monocytogenes.

Authors:  Rajesh Biswas; Abraham L Sonenshein; Boris R Belitsky
Journal:  J Bacteriol       Date:  2020-09-08       Impact factor: 3.490

Review 3.  Why is Listeria monocytogenes such a potent inducer of CD8+ T-cells?

Authors:  Alfredo Chávez-Arroyo; Daniel A Portnoy
Journal:  Cell Microbiol       Date:  2020-04       Impact factor: 3.715

4.  Genome-wide identification of Listeria monocytogenes CodY-binding sites.

Authors:  Rajesh Biswas; Abraham L Sonenshein; Boris R Belitsky
Journal:  Mol Microbiol       Date:  2020-02-05       Impact factor: 3.501

5.  A Cross-Protective Vaccine Against 4b and 1/2b Listeria monocytogenes.

Authors:  Fanzeng Meng; Tengfei Zhu; Hao Yao; Zhiting Ling; Youwei Feng; Guo Li; Jing Li; Xinyu Sun; Jiaqi Chen; Chuang Meng; Xin'an Jiao; Yuelan Yin
Journal:  Front Microbiol       Date:  2020-12-11       Impact factor: 5.640

6.  A Listeria monocytogenes-Based Vaccine Formulation Reduces Vertical Transmission and Leads to Enhanced Pup Survival in a Pregnant Neosporosis Mouse Model.

Authors:  Dennis Imhof; William Robert Pownall; Camille Monney; Anna Oevermann; Andrew Hemphill
Journal:  Vaccines (Basel)       Date:  2021-11-26

7.  Pathogenicity and virulence of Listeria monocytogenes: A trip from environmental to medical microbiology.

Authors:  Juan J Quereda; Alvaro Morón-García; Carla Palacios-Gorba; Charlotte Dessaux; Francisco García-Del Portillo; M Graciela Pucciarelli; Alvaro D Ortega
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

8.  Neurotropic Lineage III Strains of Listeria monocytogenes Disseminate to the Brain without Reaching High Titer in the Blood.

Authors:  Taylor E Senay; Jessica L Ferrell; Filip G Garrett; Taylor M Albrecht; Jooyoung Cho; Katie L Alexander; Tanya Myers-Morales; Olivia F Grothaus; Sarah E F D'Orazio
Journal:  mSphere       Date:  2020-09-16       Impact factor: 4.389

9.  Valproic acid inhibits interferon-γ production by NK cells and increases susceptibility to Listeria monocytogenes infection.

Authors:  Rodolfo Soria-Castro; Alma D Chávez-Blanco; Blanca Estela García-Pérez; Isabel Wong-Baeza; Raúl Flores-Mejía; Fabián Flores-Borja; Sergio Estrada-Parra; Iris Estrada-García; Jeanet Serafín-López; Rommel Chacón-Salinas
Journal:  Sci Rep       Date:  2020-10-20       Impact factor: 4.379

Review 10.  Clinical Experience and Recent Advances in the Development of Listeria-Based Tumor Immunotherapies.

Authors:  Mariam Oladejo; Yvonne Paterson; Laurence M Wood
Journal:  Front Immunol       Date:  2021-04-14       Impact factor: 8.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.